Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 408 for center for individualized medicine

Edit search filters
  1. Futibatinib And Pembrolizumab For The Treatment Of Advanced Or Metastatic FGF19 Positive BCLC Stage A, B, Or C Liver Cancer

    Rochester, MN

  2. Study Evaluating The Side Effects Of Bone Marrow-Derived Stem Cells When Injected Into The Facet Joints For The Treatment Of Painful Arthropathies

    Jacksonville, FL

  3. A Study To Evaluate Mesenchymal Stem Cells For Reducing Anastomotic Stenosis

    Jacksonville, FL

  4. Phase 1 Crohn's Pediatric Sub-study of MSC AFP

    Rochester, MN

  5. A Study Of The Effect Of Dalcetrapib On Cardiovascular Risk For A Genetically Defined Population Who Have Had A Recent Acute Coronary Syndrome Event

    La Crosse, WI

  6. A Study Testing The Effect Of Immunotherapy (Ipilimumab And Nivolumab) In Patients With Recurrent Glioblastoma With Elevated Mutational Burden

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Rochester, MN

  7. A Phase I Study Of Epalrestat Therapy In A Single Patient With Phosphomannomutase Deficiency (PMM2-CDG)

    Rochester, MN

  8. A Study To Evaluate Intracoronary CD34+ Cell Administration In Patients With Early Coronary Atherosclerosis

    Rochester, MN

  9. A Study Of Automated Zonal Control Of Indoor Air Pollutants On Cardiopulmonary Health, Sleep Quality, And Comfort In A Simulated Apartment

    Rochester, MN

  10. Tazemetostat In Combination With Doxorubicin As Frontline Therapy For Advanced Epithelioid Sarcoma

    Jacksonville, FL

.

Mayo Clinic Footer